Adam Afshar
Direttore/Membro del Consiglio presso Ariana Pharmaceuticals SA
Profilo
Adam Afshar was the founder of Hyde Park Global Investments LLC, which he founded in 2005 and where he held the titles of President & Chief Executive Officer.
He is currently a Director at Ariana Pharmaceuticals SA. Mr. Afshar obtained an MBA from The University of Chicago.
Posizioni attive di Adam Afshar
Società | Posizione | Inizio |
---|---|---|
Ariana Pharmaceuticals SA
Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France. | Direttore/Membro del Consiglio | 12/11/2009 |
Precedenti posizioni note di Adam Afshar
Società | Posizione | Fine |
---|---|---|
Hyde Park Global Investments LLC
Hyde Park Global Investments LLC Investment Banks/BrokersFinance Hyde Park Global Partners LLC offers a software-based investment and trading services. Its system is built primarily on genetic algorithms and other models to identify mispricing, arbitrage, and patterns in the electronic financial markets. The firm also develops robotic platform to monetize opportunities. The company was founded on May 26, 2005 and is headquartered in Atlanta, GA. | Amministratore Delegato | - |
Formazione di Adam Afshar
The University of Chicago | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Ariana Pharmaceuticals SA
Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France. | Health Technology |
Hyde Park Global Investments LLC
Hyde Park Global Investments LLC Investment Banks/BrokersFinance Hyde Park Global Partners LLC offers a software-based investment and trading services. Its system is built primarily on genetic algorithms and other models to identify mispricing, arbitrage, and patterns in the electronic financial markets. The firm also develops robotic platform to monetize opportunities. The company was founded on May 26, 2005 and is headquartered in Atlanta, GA. | Finance |
- Borsa valori
- Insiders
- Adam Afshar